| نویسندگان | vida barzyan |
| همایش | هفتمین کنگره بین المللی زیست پزشکی |
| تاریخ برگزاری همایش | 2023-11-10 - 2023-11-16 |
| محل برگزاری همایش | 1 - تهران |
| ارائه به نام دانشگاه | دانشگاه علوم پزشکی شهید بهشتی |
| نوع ارائه | سخنرانی |
| سطح همایش | بین المللی |
چکیده مقاله
Introduction: Autism spectrum disorder (ASD) consists of a genetically heterogenous
group of neurobehavioral disorders characterized by impairment in three behavioral
domains including communication, social interaction, and stereotypic repetitive
behaviors [1]. Many of the genetic defects associated with ASD encode proteins that are
relevant at the neuronal synapse or that are involved in activity-dependent changes in
neurons, including regulatory proteins such as transcription factors. Transcriptional and
splicing dysregulation or alterations in epigenetic mechanisms such as DNA methylation
or histone acetylation and modification may play a role[2]. GRIN2B is one of the genes
that impact on this disease.The GRIN2B gene provides instructions for making a protein
called GluN2B. This protein is found in nerve cells (neurons) in the brain, primarily during
development before birth[3].
Methods: In this study, GluN2B protein information was collected through NCBI,
Uniprot and PDB databases. Also, reported mutations for GRIN2B gene, which is effective
in ASD, were obtained through NCBI and Uniprot databases. Then, by using SIFT and
Polyphen sites, the effect of these mutations on the disease was investigated separately,
and common mutations were extracted and analyzed in the form of a statistical chart.
Eventually, we used NCBI to diagnosis where the most regions had mutation.
Result: According to PDB database, GluN2B receptor is a membrane protein and has 2
chains B and D and its sequence length is 862 amino acids. Based on SIFT, we found 24
single nucleoutide polymorphism (SNP) with score between 0_0.05 that was deleterious
and had pathogenicity records in UniProt and ClinVar databases and and by analyzing the
data by polyphen we got the damage rate in replacing amino acids witheachother. The
results showed that most of them were malignant and only 4 benign samples were found.
Conclusion: In this research, we analyzed GRIN2B gene mutations and their
pathogenicity. The detailed analysis of our study’s findings highlighted the significance of
variation at the Thr685, Arg682, Asn615, and Ser526 positions involved in posttranslational modifications directly or indirectly, which may be at the root of thedestabilization of the GluN2B and, as a result, the occurrence of the disease. were
identified as pathogenic, with the potential to inflict significant functional and stability
impacts on the proteins[4].